Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/7/2022
NH's DB6: Top Ten Chinese CHC Brands in 2021
6/7/2022
NH's DB6: Chinese OTC Drug Market Forecast 2026/2031
5/26/2022
Data Snapshot: Top 20 Domestic Class 1 New Drugs by Sales in 2021
5/26/2022
Ten Trends of China's Pharmaceutical Industry in 2021 (PharmCube)
5/23/2022
IQVIA: Chinese Hospital Drug Market Rose 4.2% in Q1/2021
5/20/2022
U.S., European Firms Rethink China Investment After Lockdowns
5/17/2022
433 Listed Chinese Pharma Companies Report Their Annual Performance in...
5/13/2022
Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2021
5/11/2022
China Rolls Out Five Year Plan to Develop $3.28 Trillion Bioeconomy ...
5/11/2022
Review of Top 10 Listed Chinese Biotech Firms by R&D Spending in 2021
5/9/2022
SMEI: Review of Chinese Terminal Drug Markets in 2011 – 2021
5/4/2022
How American Companies are Approaching China's Data, Privacy, and Cybe...
4/29/2022
Adagene-Sanofi's $2.5B Deal Tops March Deals in China (PharmaDJ)
4/28/2022
Sales Expenditures of Listed Chinese Pharma Companies Sharply Up Again...
4/28/2022
SMEI Revises Down Chinese Pharma Industry Growth Projection in 2022
4/28/2022
Sanofi Reports Q1/2022 Performance, Witnessing 13.4% Growth in China
4/26/2022
AstraZeneca Remain Bullish on Long-term Development in China
4/19/2022
34 HK-Listed Chinese Biopharma Firms Saw Sharp Revenue Growth in 2021 ...
4/14/2022
PhIIC: Chinese Retail Biologics Sales Led by Anti-tumor Drugs in 2021
4/11/2022
Clinical Development Strategies for Western Biotech Companies in China...
4/10/2022
Market Segmentation Snapshot of Chinese Retail Drug Market 2019-2021
4/10/2022
Chinese Pharma Profits Fell Sharply in the First Two Months of 2022
3/30/2022
IQVIA: Chinese Biopharma Investment Hotspots and Sustainability
3/21/2022
As AZ Sounds the Slowdown Alarm in China, Jefferies Beats the Drum for...
3/14/2022
China Healthcare Investment Now Up To 30% Of Global Total (PharmaDJ)
3/10/2022
AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...
3/9/2022
Snapshot of MNC Pharma's China Performance in 2021 (Updated)
2/28/2022
Most MNCs and Domestics Face Serious Headwinds, But Some Managed to Ex...
2/26/2022
IQVIA: Chinese Hospital Drug Market Rose 2.2% in MAT Q4/2021
2/22/2022
Eli Lilly Fared Well in China Last Year Despite Slowing Q4 Growth over...
Page:
10
/
38
Total number of articles:
1139
:
[First]
[<<]
[8]
[9]
[10]
[11]
[12]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit